🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Ryzodeg 100IU Penfill Cartridge is a combination of Insulin Aspart and Insulin Degludec, which are classified as Antidiabetic agents. It is prescribed to enhance glycemic control in patients diagnosed with diabetes mellitus, including both Type I and Type II diabetes.
Diabetes mellitus is a chronic condition characterized by elevated levels of glucose in the bloodstream. This can occur due to insufficient production of insulin, a hormone responsible for metabolizing glucose, by the pancreas, or due to reduced sensitivity of body cells to the actions of insulin.
Ryzodeg 100IU Penfill Cartridge is suitable for use in both adults and children aged 6 years and above. It is administered via subcutaneous injection, typically in areas such as the thigh, upper arm, or abdomen. It's important to avoid sharing needles to prevent the risk of infections. Additionally, adopting a healthy lifestyle, including abstaining from smoking and alcohol consumption, and following a balanced diet with regular physical activity, is advised in conjunction with this treatment as recommended by your doctor.
Before initiating therapy with Ryzodeg 100IU Penfill Cartridge, it's crucial to discuss with your doctor if you have any underlying liver, kidney, or heart conditions. Inform your doctor about any hormonal disorders you may have, recent changes to your diet, or if you engage in intense exercise routines as a precautionary measure.
Do not use this medication if you are experiencing hypoglycemia (low blood sugar levels). If you are pregnant or breastfeeding, consult your doctor before using Ryzodeg 100IU Penfill Cartridge.
It's unsafe to consume alcohol while using Ryzodeg Penfill.
Consult your doctor before using Ryzodeg Penfill during pregnancy due to potential risks to the developing baby.
Ryzodeg Penfill is safe to use during breastfeeding if prescribed by a doctor.
Be cautious while driving if your blood sugar levels are too low or too high, as it may affect your ability to drive.
Use Ryzodeg Penfill with caution in patients with kidney disease. Dose adjustment may be necessary, and regular monitoring of blood glucose levels is recommended.
Exercise caution when using Ryzodeg Penfill in patients with liver disease. Dose adjustment may be required, and frequent monitoring of blood glucose levels is advised.
Ryzodeg Penfill is used to treat diabetes mellitus (type 1 & type 2).
Ryzodeg Penfill combines two insulins: insulin degludec and insulin aspart, which work together to control blood sugar levels by facilitating glucose uptake and suppressing liver sugar production.
Ryzodeg SC Injection is a combination of Insulin Degludec and Insulin Aspart, both human insulin analogs.
Insulin Degludec and Insulin Aspart bind to the human insulin receptor, resulting in the same pharmacological effects as human insulin. They facilitate the uptake of glucose into muscle and fat cells while inhibiting glucose output from the liver.
Ryzodeg SC Injection is a soluble insulin product consisting of basal insulin degludec and rapid-acting prandial insulin aspart. The dosage is individualized based on the patient's needs, primarily adjusted according to fasting plasma glucose measurements.
The injection can be administered once- or twice daily with the main meal(s). In type 2 diabetes mellitus, it can be used alone, in combination with oral anti-diabetic medications, or with bolus insulin. In type 1 diabetes mellitus, it is combined with short-/rapid-acting insulin at other meals.
Before using Ryzodeg 100IU Penfill Cartridge, inform your doctor if you are taking any of the following medications:
Interaction with Food or Drink: Ryzodeg 100IU Penfill Cartridge should be administered 30 minutes before a meal.
Hypersensitivity to the active substances or any excipients is a contraindication for its use.
It falls under Pregnancy Category C, meaning animal studies have shown adverse effects on the fetus. There are no adequate and well-controlled studies in humans. It may be used in pregnant women if the potential benefits outweigh the potential risks.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.